CYTOSORBENTS CORPORATION Accumulated Other Comprehensive Income
CYTOSORBENTS CORPORATION (CTSO) had Accumulated Other Comprehensive Income of -$996.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$996.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.10M.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.98M.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.84M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$996.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$2.10M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | -$2.98M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$3.84M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$3.96M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $1.52M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $4.25M 10-K · filed 2026-03-30 | $4.25M 10-K · filed 2025-03-31 |
| 2024-09-30 | -$156.93K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $2.17M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $1.75M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $529.32K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $2.98M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.33M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $1.72M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $2.33M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $6.20M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $3.54M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $1.49M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $525.59K 10-K · filed 2023-03-09 | |
| 2021-09-30 | -$32.88K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | -$840.84K 10-Q · filed 2021-08-03 | |
| 2021-03-31 | -$576.34K 10-Q · filed 2021-05-04 | |
| 2020-12-31 | -$1.73M 10-K · filed 2022-03-10 | |
| 2020-09-30 | -$517.30K 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $530.45K 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $1.14M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $525.98K 10-K · filed 2021-03-09 | |
| 2019-09-30 | $1.16M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $344.65K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $594.46K 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $288.18K 10-K · filed 2020-03-05 | |
| 2018-09-30 | $70.10K 10-Q · filed 2018-11-06 | |
| 2018-06-30 | -$29.19K 10-Q · filed 2018-08-02 | |
| 2018-03-31 | -$690.90K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | -$360.99K 10-K · filed 2019-03-07 | |
| 2017-09-30 | -$123.28K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $156.80K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $767.13K 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $898.68K 10-K · filed 2018-03-08 | |
| 2016-09-30 | $422.72K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $483.54K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $338.82K 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $584.32K 10-K · filed 2017-03-03 | |
| 2015-09-30 | $445.71K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $495.52K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $571.88K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $227.70K 10-K · filed 2016-03-09 | |
| 2014-09-30 | $67.20K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | -$50.84K 10-Q · filed 2014-08-12 | |
| 2014-03-31 | -$55.15K 10-Q · filed 2014-05-14 | |
| 2013-12-31 | -$55.99K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $24.25K 10-Q · filed 2013-11-06 | |
| 2013-06-30 | -$15.93K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$15.06K 10-Q · filed 2013-05-15 | |
| 2012-12-31 | -$12.66K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |